Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Understand why avoiding delays in retirement planning is crucial for your financial security. Make informed decisions for your future.
26,609 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
A single-session jump can reveal more about value and risk than weeks of chatter. MGM Resorts stock jumps 16% after b...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
A luxury baby blanket priced at $1,375 has become a symbol of how motherhood in America comes with outsize costs. Thi...
Nvidia’s upcoming earnings have many traders eyeing the odds. Prediction markets are whispering a high probability of...
A quantum computing stock has tumbled roughly 40% from its peak. This article weighs the risks and potential rewards,...
Rising AI chip costs and surging demand threaten to reshape consumer budgets, credit behavior, and retirement plannin...
When a top executive sells shares as a company commits billions to its hubs, it can spark questions. This article bre...
A wave of zoning changes could unlock dense housing in cities across the U.S. This article explains how sweeping zoni...
A blue-chip industrial like Caterpillar may seem unlikely in an AI story. Yet the demand for data-center sites and th...
Insider moves often spark questions when a stock rallies. This article examines Nayax's CMO sale during a solid run, ...